New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation: Assessing the Impact on Medication Adherence

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.5, 2012-10, pp. : 287-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim Schott Gisela

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena Lip Gregory Y.H.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

Anticoagulants, renal failure and atrial fibrillation

By Genovesi Simonetta

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: New Insight in Selection of Rhythm or Rate Control Therapy and Impact of Mean Platelet Volume

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5824-5829

Bentham Science Publishers

Access to resources Recommend Favorite